🔎 Trials Near Me

Beranda › Melanoma › Ohio › Cincinnati

Uji klinis Melanoma di Cincinnati, OH

17 studi untuk Melanoma mencari peserta di lokasi sekitar Cincinnati (dalam radius sekitar 30 mil). Buka studi untuk melihat kriteria peserta dan cara menghubungi tim studi.

Teks studi resmi (Bahasa Inggris)

Merekrut peserta untuk studi di sini? Tampilkan di bagian atas halaman ini — $99 selama 30 hari →

Collecting Blood Samples From Patients With and Without Cancer to Evaluate Tests for Early Cancer Detection

Menerima pesertaStudi observasionalSukarelawan sehat diterima
  • Good Samaritan Hospital - Cincinnati, Cincinnati
  • Oncology Hematology Care Inc-Kenwood, Cincinnati
  • Bethesda North Hospital, Cincinnati
  • dan 3 lainnya
Usia 40 hingga 75 · Semua jenis kelamin · Diperbarui 2 Okt 2026 · NCT05334069

A Study With Combinations of Anti-LAG-3 and Anti-PD-1 Antibodies in Adult Participants With Advanced or Metastatic Melanoma (Harmony Head-to-Head)

Menerima pesertaFase 3
  • Oncology Hematology Care Clinical Trials, Cincinnati
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 25 Sep 2026 · NCT06246916

Study to Investigate Lifileucel Regimen Plus Pembrolizumab Compared With Pembrolizumab Alone in Participants With Untreated Advanced Melanoma.

Menerima pesertaFase 3
  • Oncology Hematology Care, Cincinnati
Usia 18 hingga 70 · Semua jenis kelamin · Diperbarui 24 Sep 2026 · NCT05727904

Comparing the Effectiveness of Less Invasive Procedures With the Current Standard of Care for the Treatment of Older Adults With Early-Stage Melanoma

Menerima pesertaFase 3
  • Good Samaritan Hospital - Cincinnati, Cincinnati
  • Bethesda North Hospital, Cincinnati
  • TriHealth Cancer Institute-Westside, Cincinnati
  • dan 1 lainnya
Usia 75 ke atas · Semua jenis kelamin · Diperbarui 24 Sep 2026 · NCT07068074

A Study to Compare the Administration of Encorafenib + Binimetinib + Nivolumab Versus Ipilimumab + Nivolumab in BRAF-V600 Mutant Melanoma With Brain Metastases

Menerima pesertaFase 2
  • Oncology Hematology Care Inc-Kenwood, Cincinnati
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 15 Sep 2026 · NCT04511013

Study of AMXT 1501 and DFMO in Combination With Standard Therapies in Advanced Solid Tumors

Menerima pesertaFase 1/2
  • University of Cincinnati Medical Center, Cincinnati
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 4 Sep 2026 · NCT07287917

Tegavivint for the Treatment of Recurrent or Refractory Solid Tumors, Including Lymphomas and Desmoid Tumors

Menerima pesertaFase 1/2
  • Cincinnati Children's Hospital Medical Center, Cincinnati
12 Months – 30 Years · Semua jenis kelamin · Diperbarui 25 Agu 2026 · NCT04851119

Project: Every Child for Younger Patients With Cancer

Menerima pesertaStudi observasional
  • Cincinnati Children's Hospital Medical Center, Cincinnati
Hingga usia 25 · Semua jenis kelamin · Diperbarui 25 Agu 2026 · NCT02402244

Safety and Tolerability Study of GIM-531 in Advanced Solid Tumors

Menerima pesertaFase 1/2
  • University of Cincinnati Cancer Center, Cincinnati
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 14 Agu 2026 · NCT06425926

A Study to Investigate the Efficacy and Safety of an Infusion of IOV-4001 in Adult Participants With Unresectable or Metastatic Melanoma or Stage III or IV Non-small-cell Lung Cancer

Menerima pesertaFase 1/2
  • University of Cincinnati, Cincinnati
Usia 18 hingga 70 · Semua jenis kelamin · Diperbarui 11 Jun 2026 · NCT05361174

Study of IDE196 in Patients With Solid Tumors Harboring GNAQ/11 Mutations or PRKC Fusions

Menerima pesertaFase 1/2
  • University of Cincinnati Cancer Center, Cincinnati
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 8 Jun 2026 · NCT03947385

Study of RMC-6236 in Patients With Advanced Solid Tumors Harboring Specific Mutations in RAS

Menerima pesertaFase 1/2
  • Christ Hospital Cancer Center, Cincinnati
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 15 Mei 2026 · NCT05379985

Promoting Immunotherapy Efficacy With Low-Dose Liver RT

Menerima peserta
  • University of Cincinnati Medical Center, Cincinnati
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 27 Feb 2026 · NCT07225036

Tebentafusp Regimen Versus Investigator's Choice in Previously Treated Advanced Melanoma (TEBE-AM)

Menerima pesertaFase 3
  • St Elizabeth Healthcare (St Elizabeth Medical Center), Edgewood · 8 mi jauhnya
  • St Elizabeth Healthcare (St Elizabeth Medical, Edgewood · 8 mi jauhnya
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 25 Feb 2026 · NCT05549297

A Phase 1/2a Study of DB-1311/BNT324 in Advanced/Metastatic Solid Tumors

Menerima pesertaFase 1/2
  • Research Site 113, Cincinnati
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 21 Nov 2025 · NCT05914116

SYNERGY-AI: Artificial Intelligence Based Precision Oncology Clinical Trial Matching and Registry

Menerima pesertaStudi observasional
  • Massive Bio SYNERGY-AI site, Cincinnati
Semua usia · Semua jenis kelamin · Diperbarui 28 Okt 2025 · NCT03452774

Melanoma Margins Trial-II: 1cm v 2cm Wide Surgical Excision Margins for AJCC Stage II Primary Cutaneous Melanoma

Menerima peserta
  • University of Cincinnati, Cincinnati
  • West Chester Hospital (OH394), West Chester · 15 mi jauhnya
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 27 Nov 2024 · NCT03860883

Uji klinis Melanoma di kota lain

Studi lain di Cincinnati

Dari ClinicalTrials.gov, data diambil 5 Okt 2026. Setiap studi menetapkan kriteria kelayakannya sendiri; tim studi yang menentukan siapa yang bisa bergabung.